Colgate-Palmolive
CL Large CapConsumer Defensive · Household & Personal Products
Mis à jour: Aug 2, 2026, 22:14 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Colgate-Palmolive en bref
Colgate-Palmolive (CL) is currently trading at 79,16 € with a market capitalization of 63,3 Md €. The trailing P/E ratio stands at 35.94x, with a forward P/E of 22.43x. The 52-week range spans from 64,63 € to 86,12 €; the current price is 8.1% below the yearly high. Year-over-year revenue growth stands at +4.9%. The net profit margin stands at 9.68%.
💰 Dividende
Colgate-Palmolive pays an annual dividend of 1,84 € per share, representing a yield of 2.32%. The payout ratio stands at 82.28%. The elevated payout ratio reflects a mature dividend policy.
📊 Avis des analystes
20 analystes évaluent Colgate-Palmolive (CL) au consensus : Acheter. L'objectif de cours moyen est de 84,97 €, soit un potentiel de +7.34% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 73,70 € à 95,37 €.
Colgate-Palmolive : la thèse d'investissement en détail
Colgate-Palmolive (CL) operates in the Consumer Defensive — specifically Household & Personal Products — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
With a gross margin near 60.43%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Return on equity of 267.37% places management among the most capital-efficient operators in the public market — every euro of shareholder capital is working hard.
Le scénario baissier
Revenue growth has slowed to just 4.9%, which is below nominal GDP — the business is no longer outgrowing the broader economy. The debt-to-equity ratio of 1388.16% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.
À surveiller
- The forward P/E of 22.43x is meaningfully below the trailing 35.94x — analysts expect earnings to step up; the next earnings release is the test.
Thèse d'investissement : forces et faiblesses
- Rentabilité élevée des capitaux propres (267.37% ROE)
- Marge brute élevée de 60.43% — signe d'un pouvoir de fixation des prix
- Consensus des analystes : Buy
- Rendement du dividende solide de 2.32%
- Free cash flow positif
- –Actuellement jugée surévaluée
- –Endettement élevé (D/E 1388.16)
Aperçu technique
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profil de risque
The data points to relatively defensive market behavior, higher leverage relative to equity.
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
More Consommation de Base stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Colgate-Palmolive?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news